Share on StockTwits

Integra LifeSciences Holdings Corp. (NASDAQ:IART) VP Brian Larkin sold 1,947 shares of the company’s stock in a transaction that occurred on Friday, August 8th. The stock was sold at an average price of $48.28, for a total value of $94,001.16. Following the completion of the transaction, the vice president now directly owns 7,069 shares in the company, valued at approximately $341,291. The sale was disclosed in a legal filing with the SEC, which is available at this link.

A number of research firms have recently commented on IART. Analysts at Oppenheimer reiterated an “outperform” rating on shares of Integra LifeSciences Holdings Corp. in a research note on Wednesday, August 6th. They now have a $57.00 price target on the stock, up previously from $55.00. Analysts at Jefferies Group raised their price target on shares of Integra LifeSciences Holdings Corp. from $54.00 to $57.00 in a research note on Wednesday, August 6th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Integra LifeSciences Holdings Corp. presently has an average rating of “Hold” and an average price target of $52.57.

Shares of Integra LifeSciences Holdings Corp. (NASDAQ:IART) traded up 0.43% during mid-day trading on Monday, hitting $48.86. 127,368 shares of the company’s stock traded hands. Integra LifeSciences Holdings Corp. has a 52-week low of $37.39 and a 52-week high of $50.25. The stock has a 50-day moving average of $47. and a 200-day moving average of $46.38. The company’s market cap is $1.593 billion.

Integra LifeSciences Holdings Corp. (NASDAQ:IART) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $0.68 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.64 by $0.04. The company had revenue of $231.40 million for the quarter, compared to the consensus estimate of $229.32 million. During the same quarter last year, the company posted $0.60 earnings per share. Integra LifeSciences Holdings Corp.’s revenue was up 12.6% compared to the same quarter last year. On average, analysts predict that Integra LifeSciences Holdings Corp. will post $2.94 earnings per share for the current fiscal year.

Integra LifeSciences Holdings Corporation (NASDAQ:IART) is an integrated medical technology company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.